Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Patients

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(6 sites)

Germany

Heloisklinikum Berlin Buch GmbH, Berlin

Klinikum Bielefeld - Onkologie, Hämatologie, Paliativmedizin, Bielefeld

Universitätsklinikum Hamburg Eppendorf (UKE), Hamburg

Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck

Universitätsklinikum Münster, Münster

Universitätsklinikum Würzburg, Würzburg